Chronic Disease Management Market Research, 2031
The global Chronic Disease Management Market size was valued at $4.90 billion in 2021 and is projected to reach $14.88 billion by 2031, growing at a CAGR of 11.8% from 2022 to 2031. Chronic disease management is an integrated care approach to managing the illness, which includes screenings, check-ups, monitoring and coordinating treatment, and patient education. It can improve the quality of life while reducing healthcare costs. Chronic disease is generally considered a condition that lasts one year or more, requires ongoing medical attention, and/or limits a person’s daily activities. Some of the most common chronic conditions are; heart disease, hypertension (high blood pressure), chronic respiratory disease, diabetes, asthma, stroke, cancer, and others. The two main risk factors associated with chronic disease are behavioral risk factors and metabolic risk factors. The behavior risk factor involves the use of tobacco, physical inactivity, unhealthy diet, and harmful use of alcohol; whereas, the metabolic risk factors are obesity, hyperglycemia, hyperlipidemia, and elevated blood pressure
The key factors that drive the growth of the chronic disease management market are the rise in the geriatric population and the increase in the prevalence of various chronic diseases such as cancer and among others. For instance, according to NCBI, chronic diseases account for about 60% of deaths and 43% of the global disease burden. In addition, according to the WHO, people of all age groups, regions, and countries are affected by non-communicable diseases (NCDs). . Moreover, the rise in the popularity of chronic disease management due to the integration of IT solutions drives the Chronic Disease Management Market growth. Furthermore, an increase in strategic initiatives such as mergers, collaborations, and acquisitions by leading players, are the key factors that provide Chronic Disease Management Market opportunity during the forecast period.
However, a lack of skilled professionals as well as a trained workforce with cross-functional skills, are expected to hinder the growth of the chronic disease management market during the forecast period.
The global Chronic Disease Management Market size was valued at $4.90 billion in 2021 and is projected to reach $14.88 billion by 2031, growing at a CAGR of 11.8% from 2022 to 2031. The Chronic Disease Management Industry is segmented on the basis of type, disease type, end user, and region. By type, the market is segmented into solutions and services. The solution segment is further classified on the basis of an on-premise solution and cloud-based solutions. On the basis of service, the segment is bifurcated into educational service, implementation service, and consultant service. On the basis of Disease Type, the segment is divided into cardiovascular disease, diabetes, cancer, asthma, a chronic obstructive pulmonary disorder, and others. On the basis of End-user, the segment is divided into providers, payers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Type Segment review
By type, the chronic disease management market is segmented into solutions and services. The solutions segment was the highest Chronic Disease Management Market sharein 2021. Owing to the increase in awareness of the use of cloud-based and on-premise solutions in healthcare leads to the growth of the chronic disease management system and drives the growth of the market.
The services are the fastest-growing segment during the forecast period. Owing to the increase in the incidence of diseases such as diabetes, cardiovascular diseases, and other chronic diseases across the globe due to surge drives the growth of the market.
Disease indication Segment Review
By disease type, the chronic disease management market is segmented into cardiovascular disease, diabetes, cancer, asthma, a chronic obstructive pulmonary disorder, and others. The diabetes segment was the highest revenue contributor to the market, owing to rise in the prevalence of diabetes due to changes in lifestyle, unhealthy diet, physical inactivity, and obesity. The rise in prevalence of type-1 and type-2 diabetes increases the demand for disease management systems to control the prevalence of this disease are the factors that are anticipated to boost the growth of the market.
Cardiovascular is estimated to be the fastest growing segment during the chronic disease management market forecast, owing to an increase in the prevalence of cardiovascular diseases such as stroke, Aortic Aneurysm, Arrhythmia, and others driving the growth of the market.
End User Segment Review
By end users, the healthcare provider segment was the highest revenue contributor to the market. An increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, heart disease, asthma, and chronic obstructive pulmonary disease. It increases the demand for health care services to provide better treatment options for the management of chronic diseases. This factor propels the growth of the chronic disease management market significantly.
The others is estimated to be the fastest growing segment during the chronic disease management market forecast, owing to the increase in the prevalence of chronic disease and the rise in the geriatric population drives the growth of the market
Region Segment Review
Region-wise, the chronic disease management market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North American market was dominant, in terms of revenue among other regions in 2021, owing to the prevalence of chronic diseases such as cancer, diabetes, cardiovascular disease, heart disease, and arthritis.
Asia-Pacific is estimated to grow at the fastest rate during the forecast period. Owing to increase in the prevalence of chronic diseases such as diabetes and cancer and the rise in the geriatric population are the factors that propel the growth of the market.
Key players that operate in the chronic disease management market are ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd. (Bengaluru), NXGN Management, LLC, Casenet, LLC, ExlServings Holdings, Inc., cliexa, Inc., Vivify Health, Inc., Allscripts Healthcare, LLC, Infosys Limited, Medecision, Altruista Health, Koninklijke Philips N.V. (Netherlands).
The chronic disease management market is segmented into Disease Type, Type and End User.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the chronic disease management market analysis from 2021 to 2031 to identify the prevailing chronic disease management market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the chronic disease management market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global chronic disease management market trends, key players, market segments, application areas, and market growth strategies.
Chronic Disease Management Market Report Highlights
| Aspects | Details |
 By Disease Type |
|
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Epic Systems Corporation, Infosys Ltd, Altruista Health, Cedar Gate Technologies, cliexa, Inc, ZeOmega, Cognizant TriZetto Software Group Inc,, Allscripts Healthcare, LLC, Medecision, Hinduja Global Solutions Ltd, Vivify Health, Inc, ExlServings Holdings, Inc, Koninklijke Philips N.V, Health Catalyst, Pegasystems Inc, NXGN Management, LLC, Casenet, LLC |
Analyst Review
This section provides various opinions of top-level CXOs in the chronic disease management market. In accordance with several interviews conducted, the chronic disease management market is expected to witness a significant growth in the future, owing to increase in the prevalence of cancer patients.
According to the perspectives of CXOs, the global chronic disease management market is expected to witness a steady growth in the future. Rise in geriatric population, and increase in number of chronic diseases such as cardiovascular diseases, heart-disease, diabetes, cancer, infectious disease, asthma, ulcerative colitis and kidney diseases. In addition, increased tobacco and alcohol consumption as well as rise in demand for chronic disease management systems/tools further propel the growth of the market. However, high cost of the treatment and high investment in the management system/tools, and lack of skilled professionals are expected to hamper the growth of the market up to some extent during the forecast period.
On the contrary, rise in advancements in technical skills method and strengthened process management of patients’ health data are expected to provide opportunities for the growth of the global chronic disease management market in the future.
Further, North America is expected to witness highest growth, in terms of revenue, owing to increase in technological advancement and increase in prevalence of chronic diseases.
Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to increase in geriatric population
North America is the largest regional market for Chronic Disease Management
The top companies to hold the market share in Chronic Disease Management are WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc
The upcoming trends are an increase in awareness regarding the healthcare management service and a rise in the prevalence of chronic diseases such as cancer, heart disease, diabetes, high blood pressure, and others
The global chronic disease management market was valued at $4,896.69 million in 2021
$14,875.48 million is the estimated industry size of Chronic Disease Management in 2031
Yes, Chronic Disease Management Market companies are profiled in the report
No, there is value chain analysis provided in the Chronic Disease Management Market report
2022-2031 forecast period is considered in the market report
Loading Table Of Content...
